Global Biodiversity Summit Sees Progress on Subsidy Reform Amid Pharma Pushback
A global biodiversity summit marks strides in subsidy reform, though pharmaceutical firms resist funding for Indigenous peoples as 2030 conservation goals ap...
POLICY WIRE — Global, International — A recent biodiversity summit has achieved measurable progress regarding the reform of subsidies, though the event faced friction as pharmaceutical companies opposed a proposed fund dedicated to Indigenous peoples.
While the international community has previously committed to halting the decline of biodiversity by 2030, the primary focus has now shifted toward translating these theoretical pledges into concrete global action.
Recent reports from the UN highlight that Asia is currently leading in documented ecosystem restoration efforts, yet significant challenges persist as financial frameworks from COP17 remain unresolved despite being halfway toward the 2030 deadline.
Reporting by Policy-Wire (PW)
